Sulfasalazine USP 500mg Enteric Coated Tablet.
Rheumatoid arthritis & Juvenile arthritis : Sulfasalazine is indicated for Rheumatic arthritis and Juvenile arthritis which has failed to responded to nonsteroidal anti-inflammatory drugs (NSAIDs). Ulcerative colitis and Crohn's disease : Sulfasalazine is also indicated for the treatment and management of severe and acute attacks of Ulcerative colitis, and in the treatment of Crohn's disease, especially in patients with colonic involvement.
Sulfasalazine USP 500mg Enteric Coated Tablet.
Rheumatoid arthritis & Juvenile arthritis : Sulfasalazine is indicated for Rheumatic arthritis and Juvenile arthritis which has failed to responded to nonsteroidal anti-inflammatory drugs (NSAIDs). Ulcerative colitis and Crohn's disease : Sulfasalazine is also indicated for the treatment and management of severe and acute attacks of Ulcerative colitis, and in the treatment of Crohn's disease, especially in patients with colonic involvement.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.